50
Participants
Start Date
December 31, 2014
Primary Completion Date
April 30, 2017
Study Completion Date
June 30, 2017
Immucillin DI4G
Immucillin DI4G was administered by topical use at 2% concentration once a day for 20 days associated with Meglumine antimoniate administered by intravenous route at a dosage of 20mg/kg/day, during 20 days.
Meglumine antimoniate
Placebo for topical use once a day at the ulcer for 20 days associated with Meglumine antimoniate administered as the standard treatment for cutaneous leishmaniasis by intravenous route at a dosage of 20mg/kg/day, during 20 days.
Corte de Pedra Health Post, Corte de Pedra
Conselho Nacional de Desenvolvimento Científico e Tecnológico
OTHER_GOV
Federal University of Bahia
OTHER
Pontificia Universidade Católica do Rio Grande do Sul
OTHER
Hospital Universitário Professor Edgard Santos
OTHER